Press Releases

Date	Title and Summary	View
Mar 30, 2016	Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference Presentation Scheduled on Wednesday, April 13, 2016 at 4:20 PM Eastern Time
Mar 09, 2016	Agile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results Cash Expected to Fund Operations Through the End of 2017
Mar 03, 2016	Agile Therapeutics to Present at the 28th Annual ROTH Conference Presentation Scheduled on Monday, March 14, 2016 at 7:30 AM Pacific Time
Feb 24, 2016	Agile Therapeutics Appoints Ajit S. Shetty, Ph.D., to Its Board of Directors Andrew Schiff, M.D. to Step Down From the Board
Feb 16, 2016	Agile Therapeutics to Present at the 2016 RBC Capital Markets' Global Healthcare Conference Presentation Scheduled on Tuesday, February 23, 2016 at 8:00 AM ET
Feb 04, 2016	Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters PRINCETON, N.J., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that the underwriters of its previously announced
Jan 22, 2016	Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock PRINCETON, N.J., Jan. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced the pricing of its underwritten public offering
Jan 21, 2016	Agile Therapeutics Announces Proposed Offering of Common Stock PRINCETON, N.J., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that it intends to offer and sell $30 million of
Jan 15, 2016	Agile Therapeutics to Present at Noble Financial Capital Markets' Twelfth Annual Equity Conference Presentation Scheduled on Monday, January 18, 2016 at 11:30 AM ET
Dec 01, 2015	Agile Therapeutics Receives Approximately $6 Million in Non-Dilutive Funding From New Jersey's Technology Business Tax Certificate Transfer Program PRINCETON, N.J., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that it has received net proceeds of approximately $6 million in